Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells. - Wikidata - awgldk - TriplyDB

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

http://www.wikidata.org/entity/Q39203018

about

Heat shock protein 90 targeting therapy: state of the art and future perspective Inhibition of Hsp90 augments docetaxel therapy in castrate resistant prostate cancer Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells.Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cells Ganetespib radiosensitization for liver cancer therapy Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.Destabilizing RET in targeted treatment of thyroid cancers.C-terminal heat shock protein 90 modulators produce desirable oncogenic properties.Heat-shock protein 90 inhibitors: will they ever succeed as chemotherapeutics?Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma.Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.

P2860

Q26776302-E28F4F1C-EA73-4CD5-8303-B8B9FE3410B1 Q28541342-862F3E74-DB99-4A97-A4EA-26CADC87EBB2 Q33820264-A5725DC5-1533-47CF-9004-AB3AE8CBD48A Q33912171-35AEC4C8-2822-4A66-85C9-42F858582E15 Q34478388-40C66F66-022D-4690-A30A-3FA9FDA3D392 Q34771715-8E38A255-B53A-4CD2-B49E-477CEE855779 Q35236805-E48AA558-D56D-4CC5-94CB-45598555CCB7 Q35818450-B03A171B-7986-455C-8965-91574D03BD8E Q36293177-2AAE807D-AE71-4824-906D-D55C9B90C411 Q36309425-A3A6CA5E-BA1D-4A86-937C-A964D480E76E Q37013260-4C56E26A-27BD-4A05-92F0-A6DF27184FDB Q37092020-58F13E64-7F09-4345-BE8D-A715504C59E6 Q37403232-FAD164D8-7B3B-4662-B628-5A5E7355A58C Q37470072-3709529B-C1C7-4D54-9F4D-BD7CE8774794 Q38740513-DF89189A-725F-4998-9F79-53A87DAA9E11 Q38819099-FECCEED0-8C01-4990-871B-25D4915F00A1 Q38906493-AE6D6375-0BC8-46A3-93DE-EBF375C34DE1 Q48596233-1E35D15E-1E90-46F1-B9E6-DB37F935673A Q51754497-AF6349B8-9159-4081-BDBB-C5A0BBE042B0 Q53663668-804536DF-098E-4501-90AD-93C263A8F4F4

P2860

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

http://www.wikidata.org/entity/Q39203018

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

@en

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

@nl

type

label

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

@en

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

@nl

prefLabel

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

@en

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

@nl

P1433

Q39203018-62913912-DFF5-43D4-BD5A-0AD77C68C93D

P1476

Q39203018-32874080-04AA-45F8-917F-581E615B6A4C

P2093

Q39203018-010E3BF1-4FD3-4351-A0EB-3E1644BD09D3

Q39203018-096D501E-1193-42BE-978E-D9E9CE85BABE

Q39203018-276ADEBC-876A-441B-A825-92845C488D81

Q39203018-291D20B4-C2E7-4011-8407-893E1A44F1FC

Q39203018-3A94BED7-10BB-4CCD-84CE-83F89024A6D1

Q39203018-3D313E95-5555-4F9E-9DA8-63E963B8522E

Q39203018-4A11D70F-C7A5-4516-8AF6-762FF9F91819

Q39203018-7BF369EB-A87A-4E49-84C3-A7BF7C4E5C03

Q39203018-8215955F-8079-49B6-ABCF-47D01B23637C

Q39203018-8AE5A495-7529-4D6C-963F-56AECAF398AD

P2860

Q39203018-012F1D32-B567-488F-901F-FB6A830BB839

Q39203018-06AD21AC-360E-4BF0-BCFA-1A1F0E7512B2

Q39203018-0F140A56-DC9F-4E82-90F2-F3EC436371F5

Q39203018-1F95C530-30FD-4F21-A443-70B2A2A42FC7

Q39203018-20B9DAD3-D045-4FA3-AB2F-882627820B4D

Q39203018-472DF931-89A7-414A-AE2E-6390DCA6C30F

Q39203018-56546FD8-BE5D-420F-BE7B-EA6A99CBC6D6

Q39203018-56BA21F2-4E1D-4642-A087-56DFA9AF7F39

Q39203018-618857E9-B3AE-4E75-A9E8-2446D9619C17

Q39203018-61CF8095-5118-4BA4-90F3-31D99172B349

P304

Q39203018-FDD5E40E-9FD3-4D6C-9DA5-2F5EDDB66ACC

P31

Q39203018-1B997AF3-FFDC-403A-8540-D5D3FCCFF52B

P356

Q39203018-9F9CC73A-368B-491F-B80C-1F85BD324B87

P433

Q39203018-D112DB2F-75FA-4614-AFE4-6BACF02C6DC2

P478

Q39203018-54881864-C9C5-45BD-B3F4-1DC1C46B9738

P50

Q39203018-39706627-CC49-4A37-87FE-E62FB0414673

Q39203018-655B8EAD-0C22-4DAC-988B-B6EBB11E851D

P577

Q39203018-1358EC58-2E35-418E-AD60-7E4A04FA0C49

P5875

Q39203018-6675FE75-C963-4DE1-9A24-FC80D8A22CEA

P698

Q39203018-65FC67A6-65BF-49A8-8800-4E703794CB9A

P932

Q39203018-F34BB457-48E1-4D90-A2AA-16BC4CA7DFF9

P356

P1433

Cancer Biology and Therapy

P1476

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells

@en

P2093

Aaron T Wild

http://www.w3.org/2001/XMLSchema#string

Anvesh Annadanam

http://www.w3.org/2001/XMLSchema#string

Danny Song

http://www.w3.org/2001/XMLSchema#string

Edward M Schaeffer

http://www.w3.org/2001/XMLSchema#string

Elwood Armour

http://www.w3.org/2001/XMLSchema#string

Jessica A Cades

http://www.w3.org/2001/XMLSchema#string

Joseph M Herman

http://www.w3.org/2001/XMLSchema#string

Khaled Aziz

http://www.w3.org/2001/XMLSchema#string

Nishant Gandhi

http://www.w3.org/2001/XMLSchema#string

Rajendra P Gajula

http://www.w3.org/2001/XMLSchema#string

P2860

NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models

Cancer statistics, 2012

NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90

The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage

Principles of cancer therapy: oncogene and non-oncogene addiction

Structure and in vivo function of Hsp90.

Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α

Inhibition of Hsp90: a multitarget approach to radiosensitization.

High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities.

P304

347-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.23626

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235379946

http://www.w3.org/2001/XMLSchema#string

P698

23358469

http://www.w3.org/2001/XMLSchema#string

P932

3667875

http://www.w3.org/2001/XMLSchema#string